Late-Onset EBV Susceptibility and Refractory Pure Red Cell Aplasia Revealing DADA2

J Clin Immunol. 2020 Aug;40(6):948-953. doi: 10.1007/s10875-020-00812-8. Epub 2020 Jul 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenosine Deaminase / genetics*
  • Adult
  • Agammaglobulinemia / complications
  • Agammaglobulinemia / genetics
  • Age of Onset
  • Biomarkers
  • Biopsy
  • Brain / diagnostic imaging
  • Brain / pathology
  • Consanguinity
  • Epstein-Barr Virus Infections / diagnosis*
  • Epstein-Barr Virus Infections / etiology*
  • Female
  • Herpesvirus 4, Human*
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology
  • Immunohistochemistry
  • Intercellular Signaling Peptides and Proteins / genetics*
  • Magnetic Resonance Imaging
  • Mutation*
  • Phenotype
  • Red-Cell Aplasia, Pure / diagnosis*
  • Red-Cell Aplasia, Pure / etiology*
  • Red-Cell Aplasia, Pure / therapy
  • Severe Combined Immunodeficiency / complications
  • Severe Combined Immunodeficiency / genetics

Substances

  • Biomarkers
  • Immunoglobulin G
  • Intercellular Signaling Peptides and Proteins
  • ADA2 protein, human
  • Adenosine Deaminase

Supplementary concepts

  • Severe combined immunodeficiency due to adenosine deaminase deficiency